Page 36 - Chen Wei News Today

Source: Highlights China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnsons one-jab shot cleared by the US drug regulator. Chinas first Ad5-nCoV COVID-19 vaccine was rolled out on Friday. Beijing: China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnsons one-jab shot cleared by the US drug regulator on Sunday (February 28). Chinas first Ad5-nCoV COVID-19 vaccine was rolled out on...

Production capacity for a COVID-19 vaccine developed by CanSino Biologics Inc (CanSinoBIO) and a military-backed institute could hit an annual half a billion doses this year, a scientist leading research for the shot told state media. "There is no problem that the annual production capacity can reach 500 million this year," Chen Wei, a researcher at the Academy of Military Medical Sciences, said in an interview with China Central Television late on Friday. Chen did not say how many d...

2021/02/25 22:11 FILE - In this Sept. 24, 2020, file photo, a worker inspects syringes of a vaccine for COVID-19 produced by Sinovac at its factory in Beijing. China a... FILE - In this Sept. 24, 2020, file photo, a worker inspects syringes of a vaccine for COVID-19 produced by Sinovac at its factory in Beijing. China approved two new more COVID-19 vaccines for wider use Thursday, adding to its growing arsenal of shots: one from CanSino Biologics, and a second one f...

CanSino Biologics Inc (CanSinoBIO) said Chinas drug regulator, the National Medical Products Administration, accepted its COVID-19 vaccine application on Wednesday. The single-dose vaccine, developed by CanSinoBIO and a team led by Chen Wei, a researcher from the Beijing-based Academy of Military Medical Sciences, will become the countrys third locally developed shot allowed for conditional use by the general public if approved.

On Chinese New Years Eve, Gou Jinbo, who was spearheading the Chinese scientific team in Pakistan for the COVID-19 vaccine Phase III clinical trials, scoffed up a few dumplings and rushed back to the clinical trial site.

China’s Role in the Coronavirus Pandemic: Negligent or Criminal? Posted on “If the United States truly respects facts, it should open the biological lab at Fort Detrick, give more transparency to issues like its 200-plus overseas bio-labs, invite WHO experts to conduct origin-tracing in the United States, and respond to the concerns from the international community with real actions.” – Chinese Foreign Ministry spokeswoman Hua Chunying at the January 18 daily press briefing  This was ...

Chinas CanSino COVID-19 vaccine shows 65.7 per cent efficacy MailOnline Reporter © Provided by Daily Mail MailOnline logo A single-dose COVID-19 vaccine developed by Chinese firm CanSino Biologics and a team led by Beijings top military bio-warfare expert is reported to show 65.7 per cent efficacy in preventing symptomatic cases.    The drug also demonstrated a 90.98 per cent success rate in stopping severe disease in an interim analysis of global trials, according to Pa...

The vaccine developed by Chinese firm CanSinoBIO and a team led by Chen Wei, Beijings top military bio-warfare expert, is reported to show 65.7 per cent efficacy in preventing symptomatic cases.

  With Chinas gross domestic product having crossed the 100 trillion yuan ($15.46 trillion) threshold in 2020, more cities have made their own substantial strides in economic output.   Despite the COVID-19 pandemic, China added six new cities with GDPs of over 1 trillion yuan last year, taking the total number of such cities in the country to 23.   The trillion-yuan benchmark is often perceived as a notion of economic prowess. Shanghai was the first city in China to hit the mark in 2006.   ...

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site. License for publishing multimedia online